Randomized Phase III Trial of Vinorelbine Plus Cisplatin Compared With Observation in Completely Resected Stage IB and II Non–Small-Cell Lung Cancer: Updated Survival Analysis of JBR-10

Journal of Clinical Oncology - United States
doi 10.1200/jco.2009.24.0333
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society of Clinical Oncology (ASCO)

Related search

Feasibility and Efficacy of Adjuvant Chemotherapy With a Split-Dose Regimen of Cisplatin Plus Vinorelbine in Japanese Patients With Completely Resected Stage II-IIIA Non-Small Cell Lung Cancer -A Retrospective Analysis-

Japanese Journal of Lung Cancer
OncologyRespiratory MedicinePulmonary
2013English

Phase III Study of Cisplatin With Pemtrexed or Vinorelbine Plus Concurrent Late Course Accelerated Hyperfractionated Radiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer

Oncotarget
Oncology
2016English

P2.16-36 Adjuvant Chemotherapy Is Effective for Completely Resected Stage IB Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Randomized Phase III Trial of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin in Chemotherapy-Naïve Korean Patients With Extensive-Disease Small Cell Lung Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2019English

Oral Vinorelbine and Cisplatin With Concomitant Radiotherapy in Stage III Non-Small Cell Lung Cancer (NSCLC): A Feasibility Study

Oncology Research and Treatment
Cancer ResearchOncologyHematology
2006English

Survival After Surgery in Stage IA and IB Non–Small Cell Lung Cancer

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2008English

Gemcitabine Plus Vinorelbine in Advanced Non-Small Cell Lung Cancer: A Phase II Study of Three Different Doses

British Journal of Cancer
Cancer ResearchOncology
2000English

Clinical Observation of Docetaxel or Gemcitabine Combined With Cisplatin in the Chemotherapy After Surgery for Stage II-III Non-Small Cell Lung Cancer

West Indian Medical Journal
Medicine
2015English

Randomized Phase II Trial of Cisplatin, Etoposide, and Radiation Followed by Gemcitabine Alone or by Combined Gemcitabine and Docetaxel in Stage III a/B Unresectable Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy